Ute Berger

3.6k citations
44 papers · 3k · 1 hit paper · h-index 23

Impact in

  • Hematology top 0.5%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 36
    • Acute Myeloid Leukemia Research 5
    • Hematopoietic Stem Cell Transplantation 1
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 5

Ute Berger

39 papers receiving 2.9k citations

Ute Berger's Hit Papers

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy 2002 · 753 citations
7530+8+16Years since publication250500750

Peers

Ute Berger
Comparison fields: 5 of 71
  • Hematology 2.3k
  • Genetics 225
  • Oncology 122
  • Rheumatology 60
  • Public Health, Environmental and Occupational Health 124
Replace Benjamin Hanfstein with:
Benjamin Hanfstein Germany
Toshiko Motoji Japan
Tanja Lahaye Germany
Laurie Catley United States
Jay P. Patel United States
Matthew S. Zabriskie United States
Iris Breitkreutz United States
Mark W. Drummond United Kingdom
Kimberly J. Hayes United States
Patrick John Hayden Ireland
Ute Berger relative to Benjamin Hanfstein Germany Benjamin Hanfstein's profile →
Citations per field
00.5×2×4×6.7×
Benjamin Hanfstein · 1×
Citations per year

Countries citing papers authored by Ute Berger

Since Specialization
Citations

This map shows the geographic impact of Ute Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Berger more than expected).

Fields of papers citing papers by Ute Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Berger. The network helps show where Ute Berger may publish in the future.

Co-authors

The 25 scholars most cited alongside Ute Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ute Berger Line = papers co-authored together Ute Berger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Hit paper breakdown →
2002753
2 2002255
3 1999230
4 2005222
5 2005206
6 2000158
7 2007121
8 1996113
9 200083
10 200878
11 200072
12 200371
13 199970
14 200370
15 200563
16 200361
17 200544
18 200440
19 201539
20 200035

About Ute Berger

Ute Berger is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Physiology and Information Systems and Management, having authored 44 papers that have together received 3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (36 papers), Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Telomeres, Telomerase, and Senescence (2 papers), Veterinary Oncology Research (1 paper), Interdisciplinary Research and Collaboration (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Hematology (2.3k citations), Genetics (225 citations), Oncology (122 citations), Rheumatology (60 citations) and Public Health, Environmental and Occupational Health (124 citations). Ute Berger has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Andreas Hochhaus, Rüdiger Hehlmann, Claudia Schoch, Nicholas C.P. Cross, Tanja Lahaye, Sebastian Kreil, Andreas Reiter, Paul La Rosée, Harald Gschaidmeier and Amie S. Corbin. Their work appears in journals such as Leukemia, Blood, Annals of Hematology, Journal of Cancer Research and Clinical Oncology and Expert Opinion on Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact